Schedule 13G ownership disclosure
ARROWHEAD PHARMACEUTICALS INC COM
COMMON STOCK · CUSIP: 04280A100
Event date: 2025-03-31
- Filing-level shares
- 6,999,249.00
- Percent of class
- 5.1%
- STATE STREET CORPORATION
Shares: 6,999,249.00 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000093751-25-000241
- Form type
- SCHEDULE 13G
- Filer
- ARROWHEAD PHARMACEUTICALS, INC.
- CIK
- CIK 879407
- Filed
- May 13, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership